🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

36 results for “Legend” Clear

  1. LUCAR-20S CAR-T cells

    Legend Biotech Corp

    Diffuse Large B Cell Lymphoma

    phase 1 small molecule terminated

    1 trial

  2. LUCAR-20SP cells

    Legend Biotech Corp

    Relapsed B-cell Non-Hodgkin Lymphoma

    phase 1 mab active

    1 trial

  3. LUCAR-B68 cells product

    Legend Biotech Corp

    Relapsed/Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  4. LUCAR-DKS1 NK cells

    Legend Biotech Corp

    Relapsed/Refractory Autoimmune Diseases

    phase 1 mab active

    1 trial

  5. LUCAR-G39D cells product

    Legend Biotech Corp

    B-Cell Non-Hodgkin Lymphoma-Recurrent

    phase 1 mab active

    1 trial

  6. LUCAR-G79 T cells

    Legend Biotech Corp

    Relapsed/Refractory Autoimmune Diseases

    phase 1 mab active

    1 trial

  7. LUCAR-G79D T cells

    Legend Biotech Corp

    Systemic Lupus Erythematosus (SLE)

    phase 1 mab active

    1 trial

  8. LVIVO-TaVec400 product

    Legend Biotech Corp

    Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)

    phase 1 mab active

    1 trial

  9. anti-CD123 CAR-T treatment

    Legend Biotech Corp

    Acute Leukemia

    phase 1 small molecule terminated

    1 trial

  10. Celastrol

    Legend Biotech Corp

    Safety Issues

    other active

    1 trial

  11. Celastrol

    Legend Biotech Corp

    Safety

    other active

    1 trial

  12. LCAR-M61S cells preparation

    Legend Biotech Corp

    Relapsed/Refractory Multiple Myeloma

    mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources